Harvard Health Blog

The SPRINT trial: A major advance in treating high blood pressure

Posted September 16, 2015, 11:53 am Deepak Bhatt, M.D., M.P.H., Editor in Chief, Harvard Heart Letter There are few advances in medicine that truly warrant an immediate change in practice, but the SPRINT trial appears to be one such study. In a recent press release, the SPRINT researchers announced that their study results showed aiming for a systolic blood pressure (the top number) of 120 mm Hg was superior to a target of…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In